B3 Holding — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Finch Therapeuticsfinchtherapeutics.comin𝕏Feb 2018
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)Matt Blischak(Chief Executive Officer)R. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsOctave Ventures LlcOCV PartnersOMX VenturesShumway CapitalHumboldt
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.